BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
8/31/16 BioTime (BTX) AST-OPC1 for Spinal Cord Injury (SCI) Subscribers Only Subscribers Only Subscribers Only
8/31/16 Novartis (NVS) Arzerra (Oncology) for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Subscribers Only Subscribers Only Subscribers Only
8/31/16 Pfizer (PFE) Xalkori for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
8/30/16 Portola (PTLA) Andexxa for Drug Toxicity Subscribers Only Subscribers Only Subscribers Only
8/30/16 Novartis (NVS) Erelzi for Psoriasis Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/31/16 Subscribers Only Subscribers Only Patent - Expiration of 30-Month Stay
08/31/16 Subscribers Only Subscribers Only Trial Announcement - Initiation
08/31/16 Subscribers Only Subscribers Only Trial Announcement - Initiation
08/31/16 Subscribers Only Subscribers Only Trial Announcement - Initiation
08/31/16 Subscribers Only Subscribers Only Trial Announcement - Initiation